Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

,Total,Units,P.A.,Higher Education,PNPI,
Units that perform R+D in Biotechnology,1.273,1.078,126,59,10,
%Units according to biotechnology used: Genetic code,43,35,91,93,60,
%Units according to biotechnology used: Functional units,49,42,89,98,60,
%Units according to biotechnology used: Cellular and tissue culturing and engineering,34,27,68,90,70,
%Units according to biotechnology used: Bioprocesses,51,49,55,92,30,
%Units according to biotechnology used: Sub-cellular organisms,16,8,54,73,40,
%Units according to biotechnology used: Bio-computing,30,22,70,85,20,
%Units according to biotechnology used: Nanobiotechnology,19,14,38,76,10,
%Units according to biotechnology used: Other,12,12,11,12,10,
Units in which biotechnology activities are:  Main and/or exclusive,575,526,37,3,9,
Units in which biotechnology activities are: A secondary line of business,249,173,37,39,.,
Units in which biotechnology activities are: A tool necessary for production,449,379,52,17,1,
%Units by field(s) of ultimate application of biotechnology use: Human health,54,48,79,95,80,
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,21,20,16,56,10,
%Units by field(s) of ultimate application of biotechnology use: Food products,34,33,22,78,10,
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,26,24,20,68,30,
%Units by field(s) of ultimate application of biotechnology use: Environment,18,15,21,71,.,
%Units by field(s) of ultimate application of biotechnology use: Industry,16,14,13,75,.,
Personnel in R&D in biotechnology (no. of persons),35.523,10.191,12.545,12.512,275,
Personnel in R&D in biotechnology (no. of persons): Researchers,22.884,5.774,7.135,9.744,231,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,12.639,4.417,5.410,2.768,44,
Personnel in R&D in biotechnology (no. of persons): women,19.474,5.525,7.462,6.323,164,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,11.830,3.015,3.974,4.705,136,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,7.645,2.511,3.488,1.618,28,
Personnel in R&D in biotechnology (FTE),24.279,7,7.191,4,9.631,4,7.374,2,82,7,
Personnel in R&D in biotechnology (FTE): Researchers,15.072,1,4.276,6,5.063,5,5.675,1,56,9,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,9.207,5,2.914,7,4.567,9,1.699,1,25,8,
Personnel in R&D in biotechnology (FTE): women,13.704,2,3.985,4,5.788,9,3.875,9,54,
Personnel in R&D in biotechnology (FTE): (women) Researchers,8.019,5,2.234,2.874,7,2.873,9,36,9,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,5.684,7,1.751,4,2.914,2,1.002,17,1,
Internal expenditure on R&D (thousands of euros),1.540.444,578.171,578.663,378.946,4.664,
1) By nature of the expense: Current expenses,1.394.144,517.601,535.547,336.445,4.552,
1.1) Remuneration to researchers,621.703,213.755,196.017,210.289,1.642,
1.2) Remuneration to technicians and assistants,272.048,98.440,127.585,45.267,757,
1.3) Other current expenses,500.394,205.406,211.946,80.890,2.153,
2) By nature of the expense: Capital expenses,146.299,60.570,43.117,42.501,111,
2.1) Land and buildings,38.481,22.609,4.286,11.587,.,
2.2) Equipment and instruments,103.079,36.169,37.163,29.636,111,
2.3) Acquisition of specific R+D software,4.739,1.793,1.668,1.278,.,
1) By origin of the funds: National funds,1.367.285,487.615,535.786,339.305,4.579,
1.1) Own funds,475.645,330.459,78.574,65.797,815,
1.2) From companies,131.856,45.462,53.216,31.579,1.600,
1.3) Public Administration funds,687.638,66.189,385.359,234.788,1.302,
1.4) From Universities,28.830,25.148,3.221,423,38,
1.5) From non profit private institutions,43.316,20.357,15.416,6.719,825,
1) By origin of the funds: Foreign funds,173.159,90.556,42.878,39.640,84,
2.1) From EU programmes,91.809,20.932,36.730,34.147,.,
2.2) Other foreign funds,81.350,69.624,6.148,5.494,84,
Purchase of services R & D in Biotechnology to (thousands of euros),197.452,166.022,30.859,569,2,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,125.047,97.455,27.061,530,1,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,72.404,68.567,3.799,39,.,
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital,48,46,60,58,60,
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,13,11,12,10,
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources,18,14,41,42,10,
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,16,14,28,31,10,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,20,17,34,44,30,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,20,17,34,39,40,
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,18,18,14,15,20,
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,35,35,38,27,10,
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost,49,49,47,61,50,
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,21,20,12,10,
%Units that have requested biotechnology patents in Biotechnology,22,15,51,75,.,
Number of patents requested,1.877,526,756,595,.,
Notas:

.
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute